MARATTO
UniversitiesAnazoeze Jude Madu
Active, last published 2026

In hemoglobinopathies and related disorders

Anazoeze Jude
Madu

ScholarScholar

Research focused on Hemoglobinopathies and Related Disorders and adjacent fields.

University of Nigeria Teaching Hospital
Claim Your Profile

15

H-index

944

Citations

Anazoeze has not officially claimed their profile. If you are Anazoeze, claim it free.

Claim Your Profile
Pioneer

Pioneer

LOCKED

Pathfinder

Pathfinder

LOCKED

Scholar

Scholar

EARNED

Innovator

Innovator

LOCKED

Inventor

Inventor

LOCKED

Catalyst

Catalyst

LOCKED

Expert

Expert

UPGRADE

01 · About the work

What I study

nazoeze Jude Madu is a researcher working on Hemoglobinopathies and Related Disorders. A fuller summary will appear once they update their profile.

02 · Reach

Publication output and reach

Anazoeze's work has been cited 944 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.

03 · Research focus

Topics

Hemoglobinopathies and Related Disorders×42Iron Metabolism and Disorders×18Blood groups and transfusion×11Blood donation and transfusion practices×7Myeloproliferative Neoplasms: Diagnosis and Treatment×6
04 · Where I am

Affiliations

Affiliation on published researchUniversity of Nigeria Teaching HospitalDrawn from the institution listed on this researcher’s published work.

Research themes (UN SDGs)

05 · Selected work

Recent publications

6 works

Expert Academic Profiles go further

Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.

Explore Expert

Are you Anazoeze?

Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.

African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.

Claim Your Profile

Free to claim · takes a minute to verify it’s you